MedTech News
Decades-old asthma theory challenged: Newly discovered molecules may be real drivers of disease
For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.
Hydrogen gas found to play key role in supporting gut health
Melbourne scientists have revealed how hydrogen is made and used in the human gut. Though infamous for making flatulence ignite, hydrogen also has a positive role supporting gut health.
Successful experiments reprogram rogue T cells for targeted autoimmune disease therapy
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the immune system doesn’t attack the body’s own tissues. The breakthroughs could usher in more personalized and targeted cell therapies for a host of autoimmune diseases.
Elkem introduces new biocompatible, electro conductive SILBIONE™ Liquid Silicone Rubber for advanced healthcare devices
YORK, S.C., Oct. 23, 2025 /PRNewswire/ — Elkem ASA (ticker: ELK), a global leader in advanced silicon-based materials, today unveiled SILBIONE™ LSR Select EC 70, a next-generation medical-grade liquid silicone rubber. Designed for wearable and diagnostic devices, the material combines high electrical conductivity, certified biocompatibility1, and enhanced process control, setting a new standard for precision healthcare applications.
Ypsomed launches YpsoLoop autoinjector platform designed for circularity
Ypsomed announced that it launched YpsoLoop, its first autoinjector platform designed for circularity.
FDA clears Mode Sensors’ fluid monitoring wearable
Mode Sensors is currently undertaking a Series A funding round to support the US market launch of its wearable sensor.
Edge Medical wins CE mark for surgical robot platform
Edge Medical announced on LinkedIn today that it received CE mark for MSP2000, its robotic-assisted “super system.”
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
FRANKLIN LAKES, N.J., Oct. 22, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States. This new innovation simplifies at-home sample collection for patients and further automates lab processing using high-tech robotics with the BD COR™ System.